Pain and Non-Pain Symptom Management in Serious Illness: Steps for Drug Therapy Selection
- Speaker:
- Mary Lynn McPherson, PharmD, PhD, BCPS, FAAHPM
- Duration:
- 2 Hours
- Format:
- Audio and Video
- Copyright:
-
Nov 15, 2024
- Product Code:
- POS078900
- Media Type:
- Digital Seminar
Description
Patients living with a serious illness commonly experience pain and non-pain symptoms. Mary Lynn McPherson, PharmD, PhD, BCPS, FAAHPM, will use a critical thinking process to illustrate the steps in drug therapy selection. Steps include identifying and assessing the problem (including multidimensional assessment and determination of the pathogenesis of symptom report), defining the therapeutic objective and relevant monitoring parameters, considerations in choosing the optimal medication(s), a monitoring plan for possible toxicity, and how to monitor and take action based on the patient’s response to the recommended drug therapy. In addition to pain management, you will discuss nausea and vomiting, anxiety, depression, dyspnea and constipation. Elevate your skills to both assess and manage common physical symptoms in serious illness including pain, and common non-pain symptoms.
Credit
Speaker
Mary Lynn McPherson, PharmD, PhD, BCPS, FAAHPM Related seminars and products
University of Maryland School of Pharmacy
Mary Lynn McPherson, Pharm.D., PhD, BCPS, FAAHPM is Professor and Executive Director, of Graduate Studies in Palliative Care (Doctor of Philosophy, Master of Science, and Graduate Certificates) at the University of Maryland, Baltimore. In addition to a PharmD degree, Dr. McPherson has a PhD in Health Professions Education. She has maintained a practice in both hospice (local and national) her entire career. Dr. McPherson is particularly interested in opioid conversion calculations, and the safe and effective use of medications in patients with a life-limiting illness, ranging from drug selection, deprescribing, and risk mitigation. She developed the first palliative care pharmacy specialty residency in the U.S. Dr. McPherson has won numerous awards for teaching, and her innovative practice in end of life care. She has published numerous articles, chapters, and five books including the best-selling “Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing.”
Speaker Disclosures:
Financial: Mary Lynn McPherson has employment relationships the University of Maryland, the University of Central Florida, American Society of Health-Systems Pharmacists Foundation, and AccentCare. She receives grants from UniversityCare Heritage Crossing Pharmacotherapy Service and ASHP. Mary Lynn McPherson receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Mary Lynn McPherson is a member of the American Academy of Hospice and Palliative Medicine, the American Association of Colleges of Pharmacy, and the American Society of Health Systems Pharmacists. She is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Determine the steps in the drug therapy selection and monitoring process for pain in serious illness.
- Differentiate between subjective and objective monitoring parameters for therapeutic effectiveness and potential toxicity.
- Evaluate best practice therapeutic approaches to non-pain symptoms in serious illness.
- Recommend a pharmacotherapy plan including monitoring for a simulated case of a patient with pain and a non-pain symptom.
Outline
Drug Therapy Selection Process- Problem identification and assessment (including multidimensional assessment)
- Define the therapeutic objective
- Monitoring parameters for therapeutic effectiveness
- Develop list of possible treatment options
- Consider patient- and drug-related variables that influence drug selection
- Select appropriate pharmacologic agent(s)
- Monitoring parameters for potential toxicity
- Implement recommendation
- Monitor patient’s response to drug therapy
- Adjust pharmacotherapy regimen as indicated
- Fifty-four year old woman with stage 4 breast cancer with mediastinal, right axillary node, and bone (rib) metastases
- Soft tissue and lymph node metastases in the right axilla, as well as an esophageal stricture from tumor in mediastinum
- Pain in four separate locations
- Assess each pain report (multidimensional pain assessment)
- Conclude pathogenesis of each pain report
- Apply drug therapy selection process – all steps
- Non-Pain Symptom Management
- Common non-pain physical symptoms associated with serious illness (e.g., nausea, anxiety, depression, dyspnea, constipation)
- Recommend pharmacologic and non-pharmacologic treatment strategies for each
Target Audience
- Social Workers
- Nurses
- Physicians
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...